Haynes and Boone, LLP and R&D Ribitzky jointly announce on Nov. 24, 2020 that they have formed a strategic alliance to counsel companies in the digital health and precision medicine sectors.
Both firms have deep experience serving these industry sectors and have joined hands to expand the scope of services that they can provide startups and more established technology companies.
R&D Ribitzky and Haynes and Boone will share best practices and strategies across a range of legal and business issues of concern to high-growth companies developing digital health and precision medicine products. As part of their new alliance, the two firms will co-produce webinars, podcasts, articles and other thought leadership that will explore cutting-edge topics and trends, spanning business and product development strategies; intellectual property, finance, regulatory and other legal issues; market data and intelligence; and case studies.
“By teaming with Haynes and Boone, we can more efficiently and seamlessly provide a one-stop shop for emerging technology companies,” said Dr. Ron Ribitzky, the founder and chief executive of R&D Ribitzky.
With offices in Boston, Washington D.C., San Francisco, Paris, and Singapore, R&D Ribitzky delivers cross-functional experts who bring together clinical and business, science and technology, digital experience and product development, marketing, sales, and ecosystem partners to its clients. R&D Ribitzky partners serve private and public-sector investors, startups and enterprise teams worldwide. For more information, please visit www.rdribitzky.com.
Haynes and Boone, LLP is an international corporate law firm with offices in Texas, New York, California, Charlotte, Chicago, Denver, Washington, D.C., London, Mexico City and Shanghai, providing a full spectrum of legal services in energy, technology, financial services and private equity. With more than 575 lawyers, Haynes and Boone is ranked among the largest U.S.-based firms by The National Law Journal, The American Lawyer and The Lawyer. It also was recognized across the board for excellence in the BTI Consulting Group’s 2020 “A-Team” report, which identifies the law firms that in-house counsel commends for providing superior client service.
The firm’s Precision Medicine and Digital Health Practice Group provides full-service counsel to the key players in precision medicine and digital health – from technology startups to established corporations, non-profit research institutions, universities, hospital systems, pharmaceuticals, and investors supporting the industry. Lawyers on team draw on the firm’s highly regarded healthcare, life sciences, technology and intellectual property experience to address trends in evolving markets, cutting-edge advances in technology, and legal and regulatory changes.